Research in contextEvidence before this studyGastric microbiota were one of the important elements of the tumor microenvironment, which participated in gastric cancer (GC) initiation, progression and metastasis. Previous studies have investigated the characteristics of the gastric microbiota in different gastric diseases, from superficial gastritis, atrophic gastritis, intestinal metaplasia to intestinal-type GC. Recently, several studies found that the gastric mucosal microbiota dysbiosis changed across stages of gastric carcinogenesis and several specific bacterial markers had been identified that could distinguish GC from other gastric diseases. However, most of these studies had always considered the whole stomach as one habitat, the differences of gastric microbiota among different stomach microhabitats in patients with GC were still unclear.The value of this studyStomach microhabitats are not always uniform; instead, they vary considerably across sites within the stomach, at the same site over time, and with the health status. The specific changes among different stomach microhabitats might help to reveal the real role of the gastric bacteria on gastric carcinogenesis. With a larger cohort of GC patients without preoperative chemotherapy enrollment, we firstly demonstrated that GC-specific stomach microhabitats determine the composition and diversity of the gastric microbiota. The most important bacterial carcinogen, *Helicobacter pylori* (HP), were significantly decreased in tumoral microhabitat, while the higher relative abundance of HP influenced the overall structure of the gastric microbiota in normal and peritumoral microhabitats. Inconsistent with previous studies, we found that bacteria from different stomach microhabitats showed different correlation network and functions.Implications of all the available evidenceWe report novel findings on the relationship between gastric microbiota and GC. Stomach microhabitats determine the overall structure and composition of the gastric microbiota, which provide new insights into the roles of gastric microbiota in different stomach microhabitats on gastric carcinogenesis, especially the pathogenesis of HP.Alt-text: Unlabelled Box

1. Introduction {#s0020}
===============

Gastric cancer (GC) is the leading cause of cancer-related mortality worldwide. According to the latest cancer statistics in China, 679,000 newly diagnosed GC cases and 498,000 GC related deaths occurred in 2015, indicating that GC is the second most common cancer after lung cancer \[[@bb0005]\]. Although the overall incidence and mortality have steadily declined in the past several decades \[[@bb0010]\], 80--90% of GC patients are diagnosed with advanced-stage disease, with a 5-year survival rate of \<30% \[[@bb0015]\]. Due to its high mortality and significant regional disparity in its distribution, GC remains an important public health burden in China.

GC is a multifactorial disease, and alterations of the tumor microenvironment are required for GC initiation, progression and metastasis. As part of the tumor microenvironment, gastric microbiota has attracted increasing attention, as it can affect cancer growth and spread in many ways. However, gastric microbiota has been relatively understudied compared to the gut microbiota. Due to acidic conditions and other antimicrobial factors, the human stomach is thought to be exclusively inhabited by *Helicobacter pylori* (HP) and viewed as an inhospitable environment for microorganisms. However, recent advances in sequencing technologies have provided a broader picture of the gastric microbiota \[[@bb0020], [@bb0025], [@bb0030], [@bb0035], [@bb0040], [@bb0045], [@bb0050], [@bb0055]\]. The tremendous complexity of the gastric microbiota shows significant differences with the microbiota described in the mouth and oesophagus, indicating that the stomach may be home to a distinct microbial ecosystem. The high number and immense diversity of bacteria within the stomach can influence metabolism, tissue development, inflammation, and immunity \[[@bb0060],[@bb0065]\], and gastric dysbiosis has been linked to various pathological conditions, including GC \[[@bb0070]\]. Aviles-Jimenez et al. demonstrated a gradual shift in the gastric microbiota profiles from non-atrophic gastritis (NAG) to intestinal metaplasia (IM) to intestinal-type GC \[[@bb0040]\], and Tseng et al. reported changes in the gastric microbiota before and after surgical treatment (subtotal gastrectomy) of GC \[[@bb0075]\]. Recently, Coker et al. demonstrated that the microbial composition changes with GC progression and they identified the differences in bacterial interactions across the different stages of gastric carcinogenesis \[[@bb0080]\].

The various habitats throughout the body contribute to the diversity and composition of the microbiota and are in a dynamic state of change according to their distinct atmospheric and nutritional compositions that provide a setting for symbiotic interactions among the various microbes within that ecosystem and the host. However, the gastric microbiota shows remarkable heterogeneity at different sites within the stomach and at the same site at different physiological and pathophysiological states \[[@bb0075]\]. Distinct pH, oxygen, nutrients, ions, and chemicals may vary considerably in tumor tissues and adjacent tumor-free tissues, which can be considered as different microhabitats that preferentially support the colonisation of certain bacterial strains. Previous studies have found that tumor-inciting microbes, such as HP, are gradually eliminated by changes in the tumor microenvironment. These changes result in an environment that is no longer hospitable to the microbe \[[@bb0085],[@bb0090]\]. As different bacterial species preferentially inhabit tumor microenvironments, changes in a particular microbial species may modify the gastric microbiota towards a more carcinogenic bacterial community. To establish the role of the gastric microbiota in GC, it is important to determine the differences in the colonisation of gastric microbiota in tumors compared to tumor-free tissues.

In the present study, a large number of GC subjects without preoperative chemotherapy was enrolled retrospectively, and mucosal tissues were collected from different stomach microhabitats. We aimed to assess the diversity and composition of the gastric microbiota across tumoral and peritumoral microhabitats, and compare them to those in the same subjects with normal gastric mucosal morphology. We emphasized the major shifts in the gastric tumor microbiota relative to that of matched, normal gastric tissue from the same individual, which allow us to survey microbial communities in stomach microhabitats with an intrinsic control for the effects of environment and host genetics. This study will provide a better understanding of the microbial transition in tumors and tumor-free tissues, and of the association between bacterial colonisation and GC development. Ultimately, this will help to identify novel microbiome-related diagnostic tools and therapeutic interventions.

2. Materials and methods {#s0025}
========================

2.1. Patients {#s0030}
-------------

In total, 276 GC patients without preoperative chemotherapy were enrolled from March 2009 to August 2013 from the First Affiliated Hospital, School of Medicine, Zhejiang University (Zhejiang, China). Stomach tissues were obtained from patients with primary GC who accepted gastrectomy. Finally, 229 tumoral tissues, 247 peritumoral tissues and 230 normal tissues were selected for microbiota analysis, which were based on DNA amount and quality appropriate for 16S rRNA gene amplification and sequence analysis. The tumor and tumor-free tissues were collected and confirmed by pathological diagnosis. \>99% of the GC was moderately/poorly differentiated. According to Lauren, GC can be divided into adenocarcinomas of diffuse and intestinal types \[[@bb0095]\]. 96 intestinal-type patients, 56 diffuse-type patients and 124 mixed-type patients were included. Patients were determined to be HP positive (HP+) by positive result in rapid urease test or histopathology. The tumor and tumor-free (2-5 cm adjacent to the cancer tissue, Peritumor; \>5 cm adjacent to the cancer tissue, Normal) tissues were collected, which were confirmed by pathological diagnosis. The clinical and pathological staging were based on the 7th edition American Joint Committee on Cancer (AJCC) cancer staging manual of GC TNM Staging \[[@bb0100]\]. Tumor stage was categorized as follows: stage I, invades mucosa or submucosa; stage II, invades mucularis mucosa; stage III, invades adventitia; stage IV, invades adjacent structures. 142 cases of early-stage GC (AJCC pathologic stage I and II) and 134 cases of late-stage GC (AJCC pathologic stage III and IV) were included \[[@bb0105]\]. The following criteria were used to exclude subjects: body mass index (BMI = weight in kilograms divided by the height in meters squared) \> 30; use of antibiotics, probiotics, prebiotics, or synbiotics in the previous month; preoperative chemotherapy, radiotherapy, or other biological treatment before gastrectomy. Basic demographic data, clinical data and information about possible confounders of microbiota analysis were collected at the time of inclusion for all GC patients ([Table 1](#t0005){ref-type="table"}). All research was approved by the Ethics Committee of the First Affiliated Hospital, School of Medicine, Zhejiang University (China). Informed written consent was obtained from each of the patients before enrollment.Table 1Summary of the study subjects\' characteristics.[⁎](#tf0005){ref-type="table-fn"}Table 1CharacteristicsPatients (n = 276)Age (means ± SD)61.11 ± 11.82Gender(Female/Male)81/195Weight(Kg, means ± SD)61.24 ± 10.19Height(cm, means ± SD)164.8 ± 7.1BMI(means ± SD)22.46 ± 3.32Complications, no Hypertension74 Diabetes mellitus17Tumor localization, no Proximal stomach35 Body/Fundus109 Antrum132Tumor differentiation, no High differentiated2 Moderately/poor differentiated274Lauren typing, no Intestinal type96 Diffuse type56 Mixed type124Tumor stage, no I (Ia, Ib)57 II (IIa, IIb)85 III (IIIa, IIIb, IIIc)121 IV13HP infection, no Positive193 Negative83Antibiotics use, no0PPI use, no276Pre-operative chemotherapy, no0Sample collection Normal, no230 Tumor stage (I/II/III/IV, no)44/68/108/10 HP infection (positive/negative, no)166/64 Peritumor, no247 Tumor stage (I/II/III/IV, no)46/72/116/13 HP infection (positive/negative, no)182/65 Tumor, no229 Tumor stage (I/II/III/IV, no)48/68/102/11 HP infection (positive/negative, no)152/77[^2]

2.2. Samples collection, DNA isolation, amplicon library construction and sequencing {#s0035}
------------------------------------------------------------------------------------

After gastrectomy, tissues were rinsed with sterile water, flash frozen in liquid nitrogen, and characterized by staff pathologists. Bacterial genomic DNA was extracted from tissue samples by using the QIAamp DNA Mini Kit (QIAGEN, Hilden, Germany) according to the manufacturer\'s instructions with minor modifications \[[@bb0110]\]. Amplicon libraries were constructed with Illumina sequencing-compatible and barcode-indexed bacterial PCR primers 319F/806R, which target the V3-V4 regions of 16S rRNA gene \[[@bb0115]\]. All PCR reactions were performed with KAPA HiFi HotStart ReadyMix using the manufacturer\'s protocol (KAPA Biosystems) and approximately 50 ng of extracted DNA per reaction. Thermocycling conditions were set at 95 °C for 1 min, 55 °C for 1 min, then 72 °C for 1 min for 30 cycles, followed by a final extension at 72 °C for 5 min. All PCR reactions were performed in 50 μl triplicates and combined after PCR. The amplicon library was prepared using a TruSeq™ DNA sample preparation kit (Illumina Inc., San Diego, CA, USA). Prior to sequencing, the PCR products were extracted with the MiniElute® Gel Extraction Kit (QIAGEN) and quantified on a NanoDrop ND-1000 spectrophotometer (Thermo Electron Corporation) and Qubit 2.0 Fluorometer (Invitrogen). The purified amplicons were then pooled in equimolar concentrations and the final concentration of the library was determined by Qubit (Invitrogen). Negative DNA extraction controls (lysis buffer and kit reagents only) were amplified and sequenced as contamination controls. Sequencing was performed on a MiSeq instrument (Illumina) using a 300 × 2 V3 kit together with PhiX Control V3 (Illumina).

2.3. Bioinformatic analysis {#s0040}
---------------------------

The 16S rRNA gene sequence data set generated from the MiSeq run were first merged and demultiplexed into per samples using the QIIME version 1.9.0 with default parameters \[[@bb0120]\]. Chimera sequences were detected and removed using the USEARCH software based on the UCHIME algorithm \[[@bb0125]\]. Open-reference operational taxonomic unit (OTU) pick was then performed with USEARCH V7 referenced against Greengenes database version 13.8 at 97% sequence similarity \[[@bb0130],[@bb0135]\]. OTUs with a number of sequences \< 0.005% of the total number of sequences were discarded as recommended \[[@bb0140]\]. The result was an OTU table, which was used for downstream analysis.

For taxonomic assignment, the most abundant sequences were chosen as the representative sequences of corresponding OTUs. Taxonomic assignment of individual datasets were classified against the Greengenes database version 13.8 using both RDP classifier and UCLUST version 1.2.22 implemented in QIIME \[[@bb0135],[@bb0145]\]. Any sequences that were identified as members of Eukarya, Archaea, Mitochondria, Chloroplasts and Cyanobacteria lineages, were removed. Alpha diversity was calculated with QIIME software with Python scripts base on the sequence similarity at 97% level, including index of observed species, abundance-based coverage estimator (ACE), Chao1 estimator, Shannon, Simpson, Evenness and PD whole tree. Sequence coverage was assessed in mothur by rarefaction curves and Good\'s coverage \[[@bb0150],[@bb0155]\]. Beta diversity was measured by unweighted and weighted UniFrac distance calculated with 10 times of subsampling by QIIME. These distances were visualized by principal coordinate analysis (PCoA) \[[@bb0160]\]. Hierarchical clustering was performed using Spearman\'s rank correlation coefficient as a distance measure and a customized script developed in R version 3.5.1. The output file was further analyzed using Statistical Analysis of Metagenomic Profiles software package (STAMP) version 2.1.3 \[[@bb0165]\].

For the predictive functional analyses, PiCRUSt software package version 1.0.0 was used to identify predicted gene families and associated pathways from inferred metagenomes of taxa of interest identified from the compositional analyses, which was based on the fact that phylogeny and function are closely linked \[[@bb0170]\]. Predicted functional genes were categorized into Clusters of Orthologous Groups (COG) and into Kyoto Encyclopedia of Genes and Genome (KEGG) orthology (KO), and compared across patient groups using STAMP. Pathways and enzymes were assigned using KEGG database options built into the pipeline. The pathways that were nonprokaryotic, had fewer than 2 sequences in each cohort, or had a difference in mean proportions \< 0.1% were excluded from analysis. The characterization of microorganismal features differentiating the gastric microbiota was performed using the linear discriminant analysis (LDA) effect size (LEfSe) method (<http://huttenhower.sph.harvard.edu/lefse>/), which emphasizes both statistical significance and biological relevance \[[@bb0175]\]. With a normalized relative abundance matrix, LEfSe uses the Kruskal-Wallis rank sum test to detect features with significantly different abundances between assigned taxa and performs LDA to estimate the effect size of each feature. A significant alpha at 0.05 and an effect size threshold of 2 were used for all biomarkers discussed in this study.

Correlation analysis was performed using sparse compositional correlation (SparCC) algorithm on the complete OTU table collapsed to the genus level, which was introduced by Friedman and Alm and was known for its robustness to the compositional effects that are influenced by the diversity and sparsity of correlation in human microbiome data sets \[[@bb0180]\]. SparCC was employed to represent co-abundance and co-exclusion networks between OTUs. For SparCC, 1000 bootstrap replicates were used to calculate significance values, and considered correlation coefficients greater or \<0.2 and −0.2 respectively and p-values \< .05. This set of iterative procedures were applied separately to normal, peritumor and tumor data sets to infer the basis correlation values within and/or between paired sampling sites. Visualization of the network was achieved using Cytoscape version 3.4.0.

2.4. Statistical analysis {#s0045}
-------------------------

For continuous variables, independent *t*-test, White\'s nonparametric *t*-test, and Mann-Whitney *U* test were applied. For categorical variables between groups, Pearson chi-square or Fisher\'s exact test was used, depending on assumption validity. For taxon among subgroups, ANOVA test was applied (Tukey-Kramer was used in Post-hoc test, Effect size was Eta-squared). For correlation analyses, Spearman\'s rank correlation test was used. False-discovery rate (FDR) was calculated according to Benjamini-Hochberg, FDR-corrected p values were denoted as Q~FDR~ and was used when performing all untargeted screening analyses of different taxa. Statistical analysis was performed using the SPSS V19.0 (SPSS Inc., Chicago, IL) and STAMP V2.1.3 \[[@bb0165]\]. GraphPad Prism version 6.0 (San Diego, CA) was used for preparation of graphs. All tests of significance were two sided, and p \< .05 or corrected p \< .05 was considered statistically significant.

2.5. Accession number {#s0050}
---------------------

The sequence data from this study were deposited in the GenBank Sequence Read Archive with the accession number SRP128749.

3. Results {#s0055}
==========

3.1. Altered gastric mucosal microbiota in GC microhabitats {#s0060}
-----------------------------------------------------------

In the present study, the possible confounders of microbiota analyses such as the gender and age of GC patients in each GC stomach microhabitat, were not significantly different (p \> .05). To investigate the gastric microbiota in different stomach microhabitats, we obtained 39,188,435 high-quality reads with an average of 55,507 reads per sample for the microbiota analysis ([Table 2](#t0010){ref-type="table"}). Good\'s estimator of coverage was nearly 100%, indicating that the identified reads represented the majority of bacterial sequences present in the stomach. Diversity indices, such as Shannon, Simpson and Heip evenness, were significantly decreased in peritumoral microhabitats ([Fig. 1](#f0005){ref-type="fig"}a--c), while richness indices, such as ACE, observed species and phylogenetic diversity (PD) whole tree, were also decreased in peritumoral and tumoral microhabitats ([Fig. 1](#f0005){ref-type="fig"}d--f). In normal microhabitats, higher species richness and more low-abundance OTUs were observed ([Fig. 1](#f0005){ref-type="fig"}g--h), with more than twice the number of unique OTUs obtained ([Fig. 1](#f0005){ref-type="fig"}i). Due to significant inter-individual variation, principal coordinate analysis (PCoA) could not separate the three microhabitats into different clusters (Fig. S1).Table 2Comparison of phylotype coverage and diversity estimation of the 16S rRNA gene libraries at 97% similarity.Table 2GroupNo. of readsNo. of OTUs[a](#tf0010){ref-type="table-fn"}Good\'s (%)ACEChao 1PD whole treeShannonSimpsonHeipNormal12,109,166990899.995%10,14510,312417.817.41550.91760.017152Peritumor14,701,752764799.994%79118184324.246.67570.89200.013567Tumor12,377,517683799.996%69647132299.677.74650.96600.031440[^3]Fig. 1The diversity and richness of the gastric microbiota in different stomach microhabitats. The diversity indices, such as Shannon (a), Simpson (b) and Heip evenness (c), and the richness indices, such as ACE (d), observed species (e) and PD whole tree (f), were used to evaluate the overall structure of the gastric microbiota in the three stomach microhabitats. Data are presented as mean ± standard deviation. Unpaired *t*-tests (two-tailed) were used to analyse variation among the three stomach microhabitats. Rarefaction curves were used to estimate the richness (at a 97% level of similarity) of the gastric microbiota among the three groups (g). The vertical axis shows the number of OTUs expected after sampling the number of tags or sequences shown on the horizontal axis. Rank abundance curves of bacterial OTUs derived from the three groups, which indicated that the majority of the OTUs were present at low abundance in the gastric microbiota samples with greater sequencing depth. (h). The Venn diagram illustrates the overlap of OTUs in the gastric microbiota among the three microhabitats (i).Fig. 1

Generally, the gastric microbiota was dominated by Proteobacteria, Firmicutes, Bacteroidetes, Actinobacteria, Acidobacteria, and Fusobacteria in descending order ([Fig. 2](#f0010){ref-type="fig"}a), which is distinct from the dominant phyla identified in the gut microbiota \[[@bb0185],[@bb0190]\]. The Proteobacteria/Firmicutes ratio was significantly increased in peritumoral microhabitats (6.41 ± 10.63 in normal microhabitat Vs. 11.09 ± 17.40 in peritumoral microhabitat, p = .000; 11.09 ± 17.40 in peritumoral microhabitat Vs. 4.66 ± 11.67 in tumoral microhabitat, p = .000; 6.41 ± 10.63 in normal microhabitat Vs. 4.66 ± 11.67 in tumoral microhabitat, p = .177; Mann-Whitney *U* test). The top 16 families and 24 genera of the gastric microbiota are shown in [Fig. 2](#f0010){ref-type="fig"}b and c. Notably, the abundant genera, such as *Helicobacter*, *Halomonas* and *Shewanella*, were enriched in the peritumoral microhabitat, while *Streptococcus*, *Selenomonas*, *Fusobacterium*, *Propionibacterium*, and *Corynebacterium* were enriched in the tumoral microhabitat. A heatmap depicting the most abundant genera identified in the gastric microbiota demonstrated correlations between the stomach microhabitats and the abundance of selected genera (Fig. S2). Discriminant analyses using LEfSe showed that 16 bacterial phylotypes were significantly different among the three microhabitats ([Fig. 2](#f0010){ref-type="fig"}d--e). More differential bacterial phylotypes were also identified in the stomach microhabitats (Fig. S3). We also observed that the species of HP, *Prevotella copri*, *Prevotella melaninogenica*, *Streptococcus anginosus*, *Propionibacterium acnes*, *Bacillus cereus*, *Bacteroides uniformis*, *Bacteroides fragilis* and *Akkermansia muciniphila* were significantly different across the three groups ([Fig. 2](#f0010){ref-type="fig"}f). In contrast to previous reports, our deep sequencing data indicated that HP, *P. copri* and *B. uniformis* were significantly decreased, while *P. melaninogenica*, *S. anginosus* and *P. acnes* were increased in the tumoral microhabitat \[[@bb0195]\].Fig. 2Different bacterial taxa among the three stomach microhabitats. Comparisons of the relative abundance of dominant bacterial taxa at the level of bacterial phylum (a), family (b) and genus (c). LEfSe identifies the taxa with the greatest differences in abundance among the three stomach microhabitats (d). Only the taxa meeting a significant LDA threshold value of \>2 are shown (e). Nine differentially abundant bacterial species were also identified among the three microhabitats (p \< .05, f; Mann-Whitney *U* tests). Data are presented as mean ± standard deviation. Mann-Whitney *U* tests were used to analyse variation among the three stomach microhabitats. §, p \< .05 between normal and peritumoral tissues; +, p \< .05 between peritumoral and tumoral tissues; \*, p \< .05 between normal and tumoral tissues.Fig. 2

The overall structure of the gastric microbiota is the result of dynamic interactions between community members. A SparCC algorithm with FDR adjustments was employed to generate correlation-based microbial interaction networks based on the relative abundance of OTUs across the three microhabitats ([Fig. 3](#f0015){ref-type="fig"}). The correlation networks formed different bacterial clusters in the three groups, with a more complex network of interactions in normal microhabitats than that in peritumoral and tumoral microhabitats, especially within or between the predominant Proteobacteria and Firmicutes phyla. The most dominant member, *Helicobacter*, was negatively correlated with *Prevotella*, *Bacteroides*, *Faecalibacterium*, *Phascolarctobacterium* and *Roseburia*. Those genera showed mainly positive correlations within the same bacterial clusters. The genera of *Halomonas*, *Shewanella*, *Methylobacterium* and *Sphingomonas* demonstrated strong positive correlations in normal microbiota. However, most of these correlations were no longer significant in peritumoral and tumoral microbiota, especially the interactions between *Helicobacter* and other genera in the two stomach microhabitats. One new, strong negative correlation was formed between *Helicobacter* and *Halomonas* in the peritumoral microbiota. We also observed that other correlations between different genera were weakened or even lost in the tumoral microbiota.Fig. 3Correlation strengths of the abundant gastric microbiota in different stomach microhabitats. Correlation network of the abundant gastric microbiota in normal microhabitat (a), peritumoral microhabitats (b) and tumoral microhabitats (c). The correlation coefficients were calculated with the Sparse Correlations for Compositional data algorithm (SparCC). Cytoscape version 3.4.0 was used for network construction. Red and green lines represent positive and negative correlations, respectively. The correlation network became simpler. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)Fig. 3

3.2. Microhabitat-specific gastric microbiota across different GC stages and types {#s0065}
----------------------------------------------------------------------------------

To identify whether the gastric microbiota was different based on GC stages, we examined the taxonomic differences between early-stage and late-stage GC in stomach microhabitats. We enrolled 142 early-stage and 134 late-stage patients, including 112/118, 118/129, and 116/113 for normal, peritumoral, and tumoral tissues, respectively. Interestingly, the bacterial diversity was not significantly different between two stages in the same microhabitat ([Fig. 4](#f0020){ref-type="fig"}a--d). Decreased diversity in peritumoral microbiota and decreased richness in peritumoral and tumoral microhabitats were observed in both stages. In addition, PCoA could not distinguish stage-related changes in these groups based on the unweighted UniFrac distance, weighted UniFrac distance and Bray-Curtis distance ([Fig. 4](#f0020){ref-type="fig"}e--j). Altered profiles of the gastric microbiota showed similar trends across different stages (Fig. S4a--c). We also found that *P. acnes*, *S. anginosus*, *P. copri* and *Sphingomonas yabuuchiae* were different among the three microhabitats in the same GC stage ([Fig. 4](#f0020){ref-type="fig"}k--n). LEfSe showed subtle clade differences among three early-stage and late-stage GC microhabitats (Figs. S5 and S6).Fig. 4Overall structure of the early-stage and late-stage gastric microbiota in the three stomach microhabitats. The α-diversity indices such as Shannon (a), Simpson (b), Chao 1 (c) and Heip evenness (d) were estimated by QIIME. Data are presented as mean ± standard deviation. Unpaired *t*-tests (two-tailed) were used to analyse variation among the three microhabitats in the same GC stage. Plots of principal coordinate analysis (PCoA) of the gastric microbiota in the early-stage and late-stage based on the unweighted UniFrac distance (e and f), weighted UniFrac distance (g and h) and Bray-Curtis distance (i and j). *Propionibacterium acnes* (k), *Streptococcus anginosus* (l), *Prevotella copri* (m) and *Sphingomonas yabuuchiae* (n) were different among the three microhabitats in the same GC stage. Data are presented as mean ± standard deviation. Mann-Whitney *U* tests were used to analyse variation among the three stomach microhabitats. \*p \< .05.Fig. 4

Overall, 96 intestinal-type patients, 56 diffuse-type patients and 124 mixed-type patients were included. Shannon was clearly lower in the peritumoral microhabitat, and Chao 1, ACE, PD whole tree and observed species were also significantly decreased in peritumoral and tumoral microhabitats, when compared between the same GC types (Fig. S7). In stomach microhabitats, several non-dominant bacterial phylotypes were different between intestinal and diffuse GC types (Fig. S8). However, there was no significant difference in the composition of the gastric microbiota between intestinal- and diffuse-GC types in the same stomach microhabitat. In combination with GC stages, these data suggested that the specific stomach microhabitats affect the diversity and composition of the gastric microbiota, regardless of GC type.

3.3. HP infection (HPI) and gastric mucosal dysbiosis {#s0070}
-----------------------------------------------------

To investigate whether HP colonisation influences the overall structure and composition of the gastric microbiota in specific microhabitats, we examined changes in the gastric microbiota in patients with histopathological HP+ and *H. pylori* negative (HP−). Approximately 70% of GC patients were diagnosed as histopathological HP+. Except for tumoral tissues, our results found a tendency towards a reduction in bacterial diversity (lower in the HP+ group; higher in the HP− group; [Fig. 5](#f0025){ref-type="fig"}a--c), while the observed species and Chao1, but not PD whole tree, were significantly higher in the normal HP− group ([Fig. 5](#f0025){ref-type="fig"}d--f) than those in both normal and peritumoral tissues. Interestingly, PCoA divided the gastric microbiota into different bacterial clusters between HP+ and HP− groups in normal and peritumoral microbiota ([Fig. 5](#f0025){ref-type="fig"}g--h), but not in tumoral microbiota ([Fig. 5](#f0025){ref-type="fig"}i). Combined with the higher HP colonisation found in these microhabitats, our results indicated that HPI may be one of the major determinants for the bacterial diversity of the gastric microbiota. The rarefaction curves showed that the richness of the gastric microbiota in HP− groups was significantly higher than that in HP+ groups ([Fig. 5](#f0025){ref-type="fig"}j). The dominant phyla of the gastric microbiota are shown in [Fig. 5](#f0025){ref-type="fig"}k, with a higher Proteobacteria/Firmicutes ratio in HP+ groups of normal and peritumoral tissues compared to matched HP− groups. Despite these samples being histopathologically HP−, the Helicobacteraceae family could also be detected by sequencing, especially in the tumoral microbiota ([Fig. 5](#f0025){ref-type="fig"}l).Fig. 5Altered gastric microbiota in the three stomach microhabitats influenced by *Helicobacter pylori* infection (HPI). HPI influenced the diversity indices of gastric microbiota in different stomach microhabitats such as Shannon (a), Simpson (b), Heip evenness (c), and the richness indices such as Chao 1 (d), PD whole tree (e) and observed species (f). Data are presented as mean ± standard deviation. Unpaired *t*-tests (two-tailed) were used to analyse variation between HP+ and HP− groups in the three stomach microhabitats. Plots of principal coordinate analysis (PCoA) of the gastric microbiota influenced by HPI in normal microhabitats (g), peritumoral microhabitats (h) and tumoral microhabitats (i) based on the unweighted UniFrac metric. Rarefaction analysis of the gastric microbiota from HP+ and HP− groups in three stomach microhabitats (j). Taxonomic differences between the gastric microbiota of HP+ and HP− groups in the three microhabitats at the phylum level (k). The different relative abundance of HP in histopathological HP+ and HP− groups in the three microhabitats (l). Data are presented as mean ± standard deviation. Mann-Whitney *U* tests were used to analyse variation between the HP+ and HP− groups in the three stomach microhabitats.Fig. 5

To identify specific changes of the gastric microbiota that correlated with HPI in each GC microhabitat, we compared the composition of the gastric microbiota between HP+ and HP− samples using LEfSe and STAMP. Consistent with the previous diversity analyses, normal and peritumoral microbiota exhibited similar changing patterns (Figs. S9a and S10a), whereas more altered bacterial phylotypes were found in normal microbiota after HPI. However, the altered phylotypes in tumoral microbiota were mostly non-dominant microorganisms, except *Helicobacter* (Fig. S11a). The community composition was further demonstrated by the significant differences between the HP+ and HP− groups in each stomach microhabitat using STAMP (Figs. S9b, S10b and S11b). At the species level, *P. copri*, *B. cereus* and *B. uniformis* were enriched in the normal HP− group, while *P. copri*, *Bacteroides plebeius*, *Akkermansia muciniphila*, *B. uniformis* and *B. fragilis* were enriched in the peritumoral HP− group. However, only *P. acnes* and two non-dominant species, such as *Acinetobacter schindleri* and *B. stercoris*, were enriched in the tumoral HP− group. In addition, these oscillating genera within each tumoral microhabitat are shown in the heatmaps, with a gradual increase of Shannon in both the HP+ and HP− groups (Figs. S12a--b, S13a--b, and S14a--b). Notably, our data demonstrate that HP is negatively correlated with Shannon regardless of the stomach microhabitat, which confirms the critical roles of HP in bacterial diversity of the gastric microbiota (Figs. S12c, S13c and S14c). ROC analysis was performed to assess the values of gastric microbiota profiling as a diagnostic tool to discriminate between HP+ and HP−. Without HP included, other differential genera provided an area under the curve (AUC) in the ROC analysis of 0.796 in normal microbiota, 0.693 in peritumoral microbiota, and 0.700 in tumoral microbiota to distinguish HPI (Figs. S12d, S13d, S14d). Our present data suggest that HPI contributes to gastric dysbiosis in stomach microhabitats.

3.4. Inferred functional changes in GC-associated gastric mucosal microbiota {#s0075}
----------------------------------------------------------------------------

The functional content of the gastric microbiota was predicted by PiCRUSt based on closed-reference OTU picking. In our present study, 19 Clusters of Orthologous Groups (COG) functional categories were tested, which identified 6 differentially abundant COGs with a Q~FDR~ \< 0.05 between normal and peritumoral microbiota, 8 between normal and tumoral microbiota, and 10 between peritumoral and tumoral microbiota ([Fig. 6](#f0030){ref-type="fig"}a). Eleven COG categories, including carbohydrate transport and metabolism, coenzyme transport and metabolism, nucleotide transport and metabolism, and amino acid transport and metabolism, exhibited the most significant differences among the three microhabitats (Q~FDR~ \< 0.05, [Fig. 6](#f0030){ref-type="fig"}b; Benjamini--Hochberg FDR method). Among these differential COGs, nucleotide transport and metabolism, amino acid transport and metabolism and inorganic ion transport and metabolism were significantly enriched in the tumoral microbiota. In addition, we also compared 64 Kyoto Encyclopedia of Genes and Genome (KEGG) pathways at level 2. At an FDR of 0.05, we identified more differentially abundant pathways between tumor microbiota and others (Fig. S15). Consistent with the significant alterations of HP-associated gastric microbiota, the KEGG pathways were changed between the HP+ and HP− groups in normal and peritumoral tissues (Fig. S16). Specifically, gastric acid secretion was significantly higher in the HP+ group of the tumoral microbiota. Together, these functional changes in the gastric microbiota may contribute to GC initiation and progression.Fig. 6PiCRUSt-based gastric microbiome study in the three different stomach microhabitats. The different bacterial functions in the three stomach microhabitats were evaluated between each other based on two-sided Welch\'s *t*-test (a). Comparisons among the three stomach microhabitats for each COG functional category shown by percentage (b). The Benjamini-Hochberg method was used for multiple testing correction based on the false discovery rate (FDR) by STAMP.Fig. 6

4. Discussion {#s0080}
=============

The GC tumor microenvironment is colonised with site-specific gastric microbiota that foster symbiotic interactions, which has been considered as an important factor in GC initiation and progression. The normal microenvironment acts as a barrier to tumorigenesis, while the tumor microenvironment can induce and promote cancer. Currently, considerable progress has been made towards understanding the altered composition and diversity of the gastric microbiota in gastric diseases, which have always considered the whole stomach as one habitat \[[@bb0020],[@bb0025],[@bb0035], [@bb0040], [@bb0045], [@bb0050], [@bb0055],[@bb0075],[@bb0080]\]. Tseng et al. found that GC tissue and neighbouring normal tissue had similar gastric microbiota in early-stage GC patients \[[@bb0075]\], while Li et al. reported that there was little difference in the gastric microbiota between antrum and body biopsy specimens \[[@bb0200]\]. However, the stomach microhabitats are not uniform; rather, they vary considerably across sites within the stomach, at the same site over time, and with health status. The different nutritional compositions within the stomach microhabitats contribute to altered diversity and composition of the gastric microbiota. It is more difficult to obtain healthy stomach tissues as controls; therefore, our present, large-scale trial study screened those confirmed GC tumoral, and peritumoral tissue, and neighbouring normal tissue from the same GC patient to investigate discrepancies in the gastric microbiota. In contrast to previous studies, our self-control study found alterations of diversity and composition of the gastric microbiota in tumor and tumor-free microhabitats, which affect both bacteria-bacteria interactions as well as bacteria-host interactions that occur in stomach microhabitats during GC development. Previous studies on colorectal cancer have suggested that different bacterial species preferentially inhabit the tumor sites but not tumor-free sites \[[@bb0205],[@bb0210]\]. The altered gastric microbiota influences inflammation and immunity both locally at the mucosal level and systemically. Our previous study demonstrated that patients with GC had increased regulatory T cells (Tregs) in peripheral blood and carcinoma tissue \[[@bb0215]\]. Disorders of the intimate interactions between the gastric microbiota in the tumor microenvironment and immune system may contribute to GC development by eliciting tumor-promoting immune responses.

To our knowledge, this is the first large-scale trial to explore specific changes of the gastric microbiota in GC stomach microhabitats using high-throughput sequencing techniques. Previous studies have found changes in the gastric microbiota across stages of gastric carcinogenesis in patients with NAG, IM and GC \[[@bb0040],[@bb0080],[@bb0220]\]. A Chinese pilot study reported that gastric microbiota features are associated with cancer risk factors and clinical outcomes in patients with gastric cardia cancer \[[@bb0025]\]. Consistent with the previous studies, we also found altered diversity and composition of the gastric microbiota in stomach microhabitats. Specifically, the bacterial richness showed a marked decreasing trend from normal to peritumoral to tumoral tissues, demonstrating that the altered microenvironment of the tumoral sites is not suitable for specific bacterial colonisation. The GC stomach microhabitat, but not GC stage, type, or cell differentiation, determined the overall structure of the gastric microbiota. Interestingly, our present study also found that the correlation network in the tumoral microhabitat became much simpler.

As a class I carcinogen of GC, HP in the tumoral sites is classically believed to contribute to GC tumorigenesis, and mass eradication of HPI significantly decreases the risk of developing cancer in infected individuals without pre-malignant lesions \[[@bb0225], [@bb0230], [@bb0235]\], reinforcing the theory that HP influences early stages in gastric carcinogenesis. HP is the strongest known risk factor for both diffuse-type and intestinal-type GC, and it uses various mechanisms to dampen host immune responses and persist in the stomach \[[@bb0240]\]. In fact, HP acts by a "hit and run" mechanism for GC and is no longer present in the intratumoral microhabitat at the time when GC is identified \[[@bb0085]\]. Our present findings confirmed that HP was significantly decreased in the tumoral microhabitat. The altered tumoral microhabitat with loss of specialized glandular tissue and decreased acid secretion might lead to the decrease of HP \[[@bb0025]\]. We also demonstrated that the presence or absence of HP led to significantly different population structures in normal and peritumoral microhabitats \[[@bb0245]\], correlating with the relative abundance of HP. A previous study found that persistent HPI of the gastric mucosa influences gastric inflammatory gene expression resulting in AG, a condition associated with a reduced capacity for gastric acid secretion and an increased risk of GC \[[@bb0245]\]. The high prevalence of HPI with reduced gastric acid secretion in peritumoral and normal microhabitats might allow for the survival and proliferation of other microbes, such as *Halomonas*, *Prevotella* and *Streptococcus*, which are normally killed by the acidic environment, resulting in the initiation of gastric carcinogenesis \[[@bb0250]\]. As a carcinogenic pathogen, HP might actively participate in GC by changing the gastric mucosal immunity, especially the imbalance of Treg/Th17. However, HP colonisation in the stomach alone is not sufficient to induce gastric carcinogenesis. Lofgren et al. demonstrated that HP-induced GC is promoted by the presence of a complex microbiota, as HP mono-associated mice developed fewer tumors than their specific pathogen-free counterparts in a hypergastrinaemic transgenic mouse model \[[@bb0255]\]. This may be explained by increased conversion of dietary nitrates, such as N-nitrosamines and N-nitrosamides, that might be attributed to HPI-associated gastric microbiota alterations, which would ultimately promote GC development \[[@bb0260],[@bb0265]\]. Compared with the tumoral microhabitat, the inferred function of the gastric microbiota by PiCRUSt changed significantly in normal and peritumoral microhabitats with or without HP colonisation, and this may contribute to the initiation of gastric carcinogenesis. In contrast to the roles of HP in the promotion of gastric carcinogenesis, HP colonisation in the stomach has been suggested to protect against oesophageal adenocarcinoma. This is due to down-modulation of gastric acid secretion \[[@bb0270]\], which emphasizes the organ-specific effects of bacterially driven carcinogenesis.

Interestingly, *P. melaninogenica*, *S. anginosus* and *P. acnes* were enriched in tumoral microhabitat and *P. copri* and *B. uniformis* decreased significantly, whereas *B. fragilis* and *A. muciniphila* showed a similar changing pattern between peritumoral and tumoral tissues. *P. acnes*, a classic skin bacterium, has recently been identified as a member of the gastric microbiota, which is a microhabitat-preferred bacterium that is found only in mucosal specimens but not in the gastric fluid \[[@bb0020],[@bb0275],[@bb0280]\]. In this study, the tumoral microhabitat was characterized by overabundance of *Propionibacterium acnes*, which is an important participant in GC tumorigenesis. *P. acnes* and its products, mainly short-chain fatty acids, trigger a possible corpus-dominant lymphocytic gastritis \[[@bb0285]\]. Tumoral microhabitat-enriched oral-originated *S. anginosus*, which was significantly decreased in the normal and peritumoral microhabitats, has been found to be associated with GC, and has significant centralities in the GC ecological network \[[@bb0080]\]. In combination with other biomarkers, such as *Peptostreptococcus stomatis*, *Parvimonas micra*, *Slackia exigua* and *Dialister pneumosintes*, *S. anginosus* distinguished GC from AG with an AUC of 0.81 \[[@bb0080]\]. Andersson et al. also demonstrated that *Streptococcus* was the most dominant genus in the stomach in the absence of HPI \[[@bb0290]\]. *P. melaninogenica*, an oral and respiratory pathogen, was also observed to be increased in the tumoral microhabitat. Dong et al. found that *P. melaninogenica* was the dominant species of the genus *Prevotella* in the stomach microbiota, making up an average of 9.17% for the NAG group and 6.95% for the chronic AG group \[[@bb0295]\]. However, unlike *S. anginosus* and *P. melaninogenica*, *P. copri* was significantly decreased in peritumoral and tumoral microhabitats. Hollister et al. reported that *P. copri* was detected in stool specimens but rarely observed in samples from other body sites \[[@bb0300]\], while our present study showed that *P. copri* was one of the dominant species in the gastric mucosal microbiota. Using 454 pyrosequencing, Scher et al. demonstrated that the presence of *P. copri* in fecal microbiota was strongly correlated with disease in new-onset untreated rheumatoid arthritis patients \[[@bb0305]\]. However, the role of *P. melaninogenica* and *P. copri* in the tumor microenvironment in GC pathogenesis requires further investigation. In addition, *B. cereus*, a food-borne pathogen that causes diarrhoeal disease in human, was found to be significantly decreased in the peritumoral microhabitat. A previous study showed that spores or vegetative *B. cereus* cells can survive the pH barrier and pepsin of the stomach and reach to the small intestine where they produce toxins in sufficient amounts \[[@bb0310]\]. As an opportunistic human pathogen, *B. fragilis* enterotoxin may have the potential to contribute to oncogenic transformation in the colon \[[@bb0315]\]. As a common member of the colonic microbiota, mucin-degrading *A. muciniphila* could increase the number of intestinal tumors, the thickness of the intestinal mucus layer, and the density of mucin-producing goblet cells, which are prime candidates for microbiota-borne modulation of intestinal tumorigenesis \[[@bb0320],[@bb0325]\]. Consistent with previous studies, both *B. fragilis* and *A. muciniphila* were enriched in peritumoral and tumoral tissues, and might participate in the process of gastric carcinogenesis. Further mechanistic studies are required to explore the roles and mechanisms of these differential bacterial species among different GC tumoral environments in GC development. Furthermore, evaluation of the interactions between GC microbiota and the gastric immune system, and specific microbial functions in cancer microenvironments might prove valuable.

In summary, we completed a large-scale analysis of GC tumors using high-throughput sequencing techniques and found that the diversity and composition of the gastric microbiota were significantly altered in different stomach microhabitats. In contrast to previous studies that considered the stomach as a whole, our study observed that the stomach microhabitats determined the overall structure and composition of the gastric microbiota, regardless of different GC stage and type. Interestingly, the carcinogenic pathogen *H. pylori* was significantly decreased in tumoral sites, which simplified the network of bacterial interactions in the gastric microbiota. The altered composition of the gastric microbiota in the three stomach microhabitats may be associated with its role in gastric carcinogenesis. However, the role of the different bacteria of the gastric microbiota in specific microhabitats remains unclear. Further studies are required to determine the gastric bacteria in tumoral microhabitats and host interactions in the process of gastric carcinogenesis.
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Supplementary materialFig. S1 3D principal coordinate analysis (PCoA) plots of individual gastric mucosal microbiota based on unweighted (a) and weighted (b) UniFrac distance in normal microhabitat (n = 230), peritumoral microhabitat (n = 247) and tumoral microhabitat (n = 229) of gastric cancer patients. Each symbol represents a sample.Fig. S2 Heatmap of the 76 key genera in gastric microbiota, which indicates the genus-level of gastric bacteria alters in normal microhabitat (n = 230), peritumoral microhabitat (n = 247) and tumoral microhabitat (n = 229) of gastric cancer patients. The colour of the spots in the panel represents the relative abundance (normalized and log10-transformed) of the genus in each sample. The relative abundance of the bacteria in each genus is indicated by a gradient of colour from red (low abundance) to blue (high abundance). The genera were organized by Spearman\'s correlation analysis based on their relative abundances. The taxonomic classifications of the genus are shown on the right. The corresponding Shannon index in each sample is shown under the heatmap.Fig. S3 Taxonomic differences of the gastric mucosal microbiota among three stomach microhabitats. Related cladogram showing bacterial taxa significantly enriched in each group using the LDA model results for the bacterial hierarchy (upper panel) and principal coordinate analysis (PCoA) for gastric microbiota at three microhabitats (lower panel).Fig. S4 Tumor stages of gastric cancer related changes of gastric mucosal microbiota. Cladogram represents the features of gastric mucosal microbiota among early-stage and late-stage of gastric cancer using the LDA model results for the bacterial hierarchy (a). Comparisons of the relative abundance at the level of bacterial phylum and genus in early stage (b) and late-stage (c) among the three stomach microhabitats. The data are presented as the mean ± standard deviation. Mann-Whitney *U* tests were used to analyse variation among three stomach microhabitats.^⁎^, p \< .05; ^\#^, *p* \< .01.Fig. S5 Taxonomic differences of the gastric mucosal microbiota in early-stage of GC among three stomach microhabitats using LEfSe.Fig. S6 Taxonomic differences of the gastric mucosal microbiota in late-stage of GC among three stomach microhabitats using LEfSe.Fig. S7 Comparison of the diversity and richness of gastric mucosal microbiota between intestinal-type and diffuse-type of gastric cancer in each stomach microhabitat. The diversity indices of gastric microbiota such as Shannon (a), Simpson (b), and the richness indices such as ACE (c), Chao 1 (d), PD whole tree (e) and observed species (f) were used to evaluated the overall structure of gastric microbiota between two types of gastric cancer in each microhabitat. The data are presented as the mean ± standard deviation. Unpaired *t*-tests (two-tailed) were used to analyse variation between intestinal- and diffuse-type of GC in the three stomach microhabitats.Fig. S8 Taxonomic differences of the gastric mucosal microbiota between intestinal-type and diffuse-type of gastric cancer. Comparisons of the relative abundance of gastric mucosal microbiota at the level of bacterial phylum, family and genus between intestinal- and diffuse-type of gastric cancer using STAMP with Benjamini-Hochberg correction (Q~FDR~).Fig. S9 Taxonomic differences of the gastric mucosal microbiota between histopathological *H. pylori* positive and negative (HP*+* and HP−) groups of gastric cancer in normal microhabitat. LEfSe identified the features of gastric microbiota that are discriminative with respect to *H. pylori* infection (HPI) in normal microhabitat using the LDA model results for the bacterial hierarchy, while LDA coupled with effect size measurements identified the most differentially abundant taxa between the two groups (a). Comparisons of the relative abundance of gastric mucosal microbiota at the level of bacterial phylum, family and genus between HP*+* and HP− groups of gastric cancer using STAMP with Benjamini-Hochberg correction (Q~FDR~, b).Fig. S10 Taxonomic differences of the gastric mucosal microbiota between histopathological HP*+* and HP− groups of gastric cancer in peritumoral microhabitat. LEfSe identified the features of gastric microbiota that are discriminative with respect to HPI in peritumoral microhabitat using the LDA model results for the bacterial hierarchy, while LDA coupled with effect size measurements identified the most differentially abundant taxa between the two groups (a). Comparisons of the relative abundance of gastric mucosal microbiota at the level of bacterial phylum, family and genus between HP*+* and HP− groups of gastric cancer using STAMP with Benjamini-Hochberg correction (Q~FDR~, b).Fig. S11 Taxonomic differences of the gastric mucosal microbiota between histopathological HP*+* and HP− groups of gastric cancer in tumoral microhabitat. LEfSe identified the features of gastric microbiota that are discriminative with respect to HPI in tumoral microhabitat using the LDA model results for the bacterial hierarchy, while LDA coupled with effect size measurements identified the most differentially abundant taxa between the two groups (a). Comparisons of the relative abundance of gastric mucosal microbiota at the level of bacterial phylum, family and genus between HP*+* and HP− groups of gastric cancer using STAMP with Benjamini-Hochberg correction (Q~FDR~, b).Fig. S12 Comparison of the gastric mucosal microbiota between histopathological HP*+* and HP− groups of gastric cancer in normal microhabitat. Heatmap indicating the different abundant genera between HP*+* and HP− groups of the normal microhabitat (a), and the corresponding Shannon index shows from low to high in each group (b). Correlation between Shannon index and the relative abundance of HP (c). Receiver operating characteristic (ROC) curves for differential genera such as *Prevotella*, *Faecalibacterium*, *Bifidobacterium*, *Phascolarctobacterium*, *Roseburia, Streptococcus*, *Halomonas*, *Blautia*, *Shewanella*, *Ruminococcus* and *Dialister* that were used to predict the presence of HPI in normal microhabitat (d).Fig. S13 Comparison of the gastric mucosal microbiota between histopathological HP*+* and HP− groups of gastric cancer in peritumoral microhabitat. Heatmap indicating the different abundant genera between HP*+* and HP− groups of the peritumoral microhabitat (a), and the corresponding Shannon index shows from low to high in each group (b). Correlation between Shannon index and the relative abundance of HP (c). Receiver operating characteristic (ROC) curves for differential genera such as *Prevotella*, *Faecalibacterium*, *Bifidobacterium*, *Phascolarctobacterium*, *Veillonella*, *Megamonas*, *Gemmiger*, *Halomonas*, *Blautia* and *Shewanella* that were used to predict the presence of HPI in peritumoral microhabitat (d).Fig. S14 Comparison of the gastric mucosal microbiota between histopathological HP*+* and HP− groups of gastric cancer in tumoral microhabitat. Heatmap indicating the different abundant genera between HP*+* and HP− groups of the tumoral microhabitat (a), and the corresponding Shannon index shows from low to high in each group (b). Correlation between Shannon index and the relative abundance of HP (c). Receiver operating characteristic (ROC) curves for differential genera such as *Prevotella*, *Faecalibacterium*, *Bifidobacterium*, *Ruminococcus*, *Bacteroides*, *Carnobacterium*, *Paracoccus*, *Novosphingobium* and *Akkermansia* that were used to predict the presence of HPI in tumoral microhabitat (d).Fig. S15 Differentially abundant KEGG pathways were identified between tumor microbiota and others at an FDR of 0.05. The different KEGG pathways at level 2 were identified between normal and peritumoral microbiota (a), normal and tumoral microbiota (b), peritumoral and tumoral microbiota (c). Benjamini-Hochberg method was used for multiple testing correction based on false discovery rate (FDR) by STAMP.Fig. S16 Differentially abundant KEGG pathways were identified between between histopathological HP*+* and HP− groups in each tumoral microhabitat at an FDR of 0.05. The different KEGG pathways at level 2 were identified between histopathological HP*+* and HP− groups in normal microhabitats (a), peritumoral microhabitat (b), and tumoral microhabitat (c). Benjamini-Hochberg method was used for multiple testing correction based on false discovery rate (FDR) by STAMP.Image 1
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